latest update:
[TrialBase DB]

trial summary · NCT07738874

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care

Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care 3 (BabySTEPS3)

Trial record from the TrialBase DB dataset, status RECRUITING, condition Retinopathy of Prematurity (ROP), sponsored by Duke University. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07738874phase —enrollment 175start 2026-12-01

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

Retinopathy of prematurity (ROP) is a disorder of development of the retina and its vasculature that can impact vision in vulnerable preterm neonates for a lifetime. A major barrier to improving ROP outcomes is the lack of easy access and low stress means to obtain objective measures of ROP disease severity across the retina in these infants. The long-term goal of this program is to provide information which will improve preterm infant health and vision via objective bedside imaging and analysis that characterizes retina-wide ROP level of disease, its response to treatment and development, and to rapidly translate this for better early intervention and improved future vision care.

Source record: https://clinicaltrials.gov/study/NCT07738874

Facts

registry idNCT07738874
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionRetinopathy of Prematurity (ROP)
sponsorDuke University
sponsor classOTHER
enrollment175
start date2026-12-01
primary completion2031-06-30
completion2031-12-31
results postednot reported

Conditions

  • Retinopathy of Prematurity (ROP)

Interventions

  • Ultra-widefield Optical Coherence Tomography (UWF-OCT)
  • Wide-field ophthalmic imaging system

Countries

  • United States

Intervention types: DEVICE

Work with this record